Nephro Care

{
  "main_header": {
    "sid": 10039307,
    "name": "Nephro Care",
    "stock_name": "Nephro Care",
    "full_name": "Nephro Care India Ltd",
    "name_url": "stocks-analysis/nephro-care",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "98.65",
    "chg": 2.4,
    "chgp": "2.49%",
    "dir": 1,
    "prev_price": "96.25",
    "mcapval": "157.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "NEPHROCARE",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE0SUN01013",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": 8000,
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nephro-care-10039307-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "How has been the historical performance of Nephro Care?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-nephro-care-3695831",
        "imagepath": "",
        "date": "2025-11-13 00:41:55",
        "description": "Answer:\nThe historical performance of Nephro Care shows significant growth over the years, particularly from March 2022 to March 2025.\n\nBreakdown:\nNephro Care's net sales have increased dramatically from 3.42 Cr in March 2022 to 46.03 Cr in March 2025, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 3.42 Cr in March 2022 to 46.03 Cr in March 2025. The company's total expenditure also grew, reaching 40.16 Cr in March 2025 from just 3.30 Cr in March 2022. Operating profit, excluding other income, peaked at 5.87 Cr in March 2025, although it was slightly lower than the previous year's 6.47 Cr. Profit before tax showed fluctuations, with a high of 6.22 Cr in March 2024 but dropping to 4.83 Cr in March 2025. Profit after tax reached 3.64 Cr in March 2025, down from 4.50 Cr in March 2024, yet still a significant improvement from the loss of 0.01 Cr in March 2022..."
      },
      {
        "title": "Why is Nephro Care falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-nephro-care-fallingrising-3681676",
        "imagepath": "",
        "date": "2025-11-08 00:40:37",
        "description": "As of 07-Nov, Nephro Care India Ltd is experiencing a decline in its stock price, currently at 128.00, which reflects a decrease of 0.55 or 0.43%. The stock has been trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the stock has shown a significant drop in performance over various periods, with a 1-week decline of 6.09% and a year-to-date decrease of 30.43%. However, there has been a notable increase in investor participation, with delivery volume rising by 85.67% against the 5-day average, suggesting some interest despite the overall downward movement. Unfortunately, there is no information available regarding positive or negative factors that could further clarify the stock's recent performance.\n\nIn the broader market context, Nephro Care's short-term performance has been considerably worse than the benchmark, with the Sensex onl..."
      }
    ],
    "total": 196,
    "sid": "10039307",
    "stock_news_url": "https://www.marketsmojo.com/news/nephro-care-india-10039307"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "13 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

How has been the historical performance of Nephro Care?

2025-11-13 00:41:55

Answer: The historical performance of Nephro Care shows significant growth over the years, particularly from March 2022 to March 2025. Breakdown: Nephro Care's net sales have increased dramatically from 3.42 Cr in March 2022 to 46.03 Cr in March 2025, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 3.42 Cr in March 2022 to 46.03 Cr in March 2025. The company's total expenditure also grew, reaching 40.16 Cr in March 2025 from just 3.30 Cr in March 2022. Operating profit, excluding other income, peaked at 5.87 Cr in March 2025, although it was slightly lower than the previous year's 6.47 Cr. Profit before tax showed fluctuations, with a high of 6.22 Cr in March 2024 but dropping to 4.83 Cr in March 2025. Profit after tax reached 3.64 Cr in March 2025, down from 4.50 Cr in March 2024, yet still a significant improvement from the loss of 0.01 Cr in March 2022...

Read full news article

Why is Nephro Care falling/rising?

2025-11-08 00:40:37

As of 07-Nov, Nephro Care India Ltd is experiencing a decline in its stock price, currently at 128.00, which reflects a decrease of 0.55 or 0.43%. The stock has been trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the stock has shown a significant drop in performance over various periods, with a 1-week decline of 6.09% and a year-to-date decrease of 30.43%. However, there has been a notable increase in investor participation, with delivery volume rising by 85.67% against the 5-day average, suggesting some interest despite the overall downward movement. Unfortunately, there is no information available regarding positive or negative factors that could further clarify the stock's recent performance. In the broader market context, Nephro Care's short-term performance has been considerably worse than the benchmark, with the Sensex onl...

Read full news article

View All News